List of largest pharmaceutical companies by revenue

The following is a list of the top independent pharmaceutical & biotechnology companies ranked by their revenue generated ($10 billion) in the respective financial year, it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

The change is the companies relative position in this list, compared to their relative position in the prior year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the previous year, red cells indicate those years where there has been a decrease.

Top pharmaceutical companies with revenue greater than $10 billion

Rank Chg Company 2018
USD billions
2017
USD billions
2016
USD billions
2015
USD billions
2014
USD billions
2013
USD billions
2012
USD billions
2011
USD billions
1SteadyUnited States Johnson & Johnson
NYSE: JNJ
40.81 (Q2)[1] 76.50[2] 71.89[3] 70.10[4] 74.30[5] 71.31[6] 67.20[7] 65.00[8]
2SteadySwitzerland Roche
OTCQX: RHHBY
28.30 (Q2)[9] 57.37[10] 50.11[11] 47.70[12] 49.86[13] 48.53[14] 47.80[15] 45.21[16]
3SteadyUnited States Pfizer
NYSE: PFE
26.37 (Q2)[17] 52.54[18] 52.82[19] 48.85[20] 49.61[21] 51.58[22] 58.99[23] 65.26[24]
4SteadySwitzerland Novartis
NYSE: NVS
25.85 (Q2)[25] 49.11[26] 48.52[27] 49.41[28] 58.00[29] 57.36[30] 56.67[31] 58.57[32]
5Increase 1Germany Bayer
FWB: BAYN
21.80 (Q2) 27.76[33] 25.27[34] 24.09[35] 25.47[36] 24.17[37] 24.30[38] 23.11[39]
6Increase 1United States Merck & Co.
NYSE: MRK
20.51 (Q2)[40] 40.10[41] 39.80[42] 39.50[43] 42.24[44] 44.03[45] 47.27[46] 48.05[47]
7Decrease 1United Kingdom GlaxoSmithKline
LSE: GSK
19.74 (Q2)[48] 42.05[49] 34.79[50] 29.84[51] 37.96[52] 41.61[53] 39.93[54] 41.39[55]
8SteadyFrance Sanofi
NYSE: SNY
18.65 (Q2)[56] 42.91[57] 36.57[58] 36.73[59] 43.07[60] 42.08[61] 46.41[62] 44.34[63]
9SteadyUnited States AbbVie
NYSE: ABBV
16.21 (Q2)[64] 28.22[65] 25.56[66] 22.82[67] 19.96[68] 18.79[69]
10SteadyUnited States Abbott Laboratories
NASDAQ: ABT
15.16 (Q2)[70] 27.39[71] 20.85[72] 20.41[73] 20.25[74] 21.85[75] 39.87[76] 38.85[77]
11SteadyUnited States Eli Lilly & Co
NYSE: LLY
14.08 (Q2)[78] 22.90[79] 21.22[80] 20.00[81] 19.62[82] 23.11[83] 22.60[84] 24.29[85]
12SteadyUnited States Amgen
NASDAQ: AMGN
11.61 (Q2)[86] 22.80[87] 22.99[88] 21.66[89] 20.06[90] 18.68[91] 17.30[92] 15.58[93]
13Increase 4United States Bristol-Myers Squibb
NASDAQ: BMY
10.90 (Q2)[94] 20.80[95] 19.43[96] 16.56[97] 15.88[98] 16.39[99] 17.62[100] 21.24[101]
14Increase 1United States Gilead Sciences
NASDAQ: GILD
10.54 (Q2)[102] 25.70[103] 30.39[104] 32.15[105] 24.47[106] 10.80[107] 9.70[108] 8.39[109]
15Decrease 1United Kingdom AstraZeneca
LSE: AZN
10.33 (Q2)[110] 22.47[111] 23.00[112] 24.71[113] 26.10[114] 25.71[115] 27.97[116] 33.59[117]
16SteadyIsrael Teva Pharmaceutical Industries
NASDAQ: TEVA
9.77 (Q2)[118] 22.40[119] 21.90[120] 20.00[121] 20.27[122] 20.31[123] 18.31[124] 16.12[125]
17SteadyGermany Boehringer Ingelheim
Private
21.67[126] 17.54[127] 16.41[127] 17.70[127] 18.68[127] 18.89[127] 18.34[127]
18SteadyGermany Merck Group
ETR: MRK
8.83(Q2)[128] 18.70[129] 16.62[130] 14.25[131] 15.29[132] 14.73[133] 14.36[134] 14.31[135]
19SteadyDenmark Novo Nordisk
NYSE: NVO
8.41 (Q2)[136] 18.77[137] 16.61[138] 16.06[139] 15.83[140] 14.88[141] 13.48[142] 11.56[143]
20SteadyRepublic of Ireland Allergan plc
NYSE: AGN
7.79 (Q2)[144] 15.94[145] 14.57[145] 15.07[145] 12.88[146] 8.68[147] 5.91[148] 4.58[149]
20SteadyJapan Takeda Pharmaceutical
TYO: 4502
4.05 (Q1) 16.70[150] 15.96 14.93 16.84 17.36 18.91 17.80
21SteadyRepublic of Ireland Shire
NASDAQ: SHPG
7.58 (Q2)[151] 14.40[152] 11.40[153] 6.42[154] 6.00[155] 4.76[156] 4.68[157] 3.50[158]
22SteadyUnited States Celgene
NASDAQ: CELG
7.34 (Q2)[159] 13.00 11.23 9.26 7.67 6.49 5.51 4.84
23SteadyUnited States Biogen
NASDAQ: BIIB
6.53 (Q2)[160] 12.30[161] 11.40[162] 10.80[163] 9.70[164] 6.90[165] 5.50[166] 5.00[167]

See also

References

  1. Johnson, Johnson &. "Johnson & Johnson Reports 2018 First-Quarter Results:". www.prnewswire.com.
  2. "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  3. "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  4. "Johnson & Johnson Reports 2015 Fourth-Quarter Results:".
  5. "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  6. "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  7. "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results:".
  8. "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:".
  9. https://www.fiercepharma.com/pharma/roche-ups-2018-guidance-again-as-ocrevus-steams-pass-blockbuster-threshold
  10. "Roche reports good results in 2017". www.roche.com.
  11. https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf
  12. https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf
  13. https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf
  14. https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf
  15. https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf
  16. https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf
  17. https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q2/Q2-2018-PFE-Earnings-Release.pdf
  18. https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
  19. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
  20. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
  21. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
  22. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
  23. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
  24. https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf
  25. https://www.novartis.com/sites/www.novartis.com/files/q2-2018-media-release-en.pdf
  26. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2017-en.pdf
  27. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
  28. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
  29. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
  30. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
  31. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
  32. https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf
  33. http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
  34. http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
  35. http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
  36. http://www.annualreport2014.bayer.com/en/bayer-annual-report-augmented-version-2014.pdfx
  37. https://www.bayer.com/en/ar-2013.pdfx
  38. https://www.bayer.com/en/ar-2012.pdfx
  39. https://www.bayer.com/en/ar-2011.pdfx
  40. http://investors.merck.com/news/press-release-details/2018/Merck-Announces-Second-Quarter-2018-Financial-Results/default.aspx
  41. LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket".
  42. http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
  43. http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
  44. http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
  45. http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
  46. http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
  47. http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf
  48. https://www.gsk.com/media/5011/q2-2018-results-and-rd-update-announcement.pdf
  49. https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
  50. https://www.gsk.com/media/3609/annual-report-2016.pdf
  51. https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
  52. https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
  53. https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
  54. https://www.gsk.com/media/2694/annual-report-2012.pdf
  55. https://www.gsk.com/media/2696/annual-report-2011.pdf
  56. http://mediaroom.sanofi.com/first-quarter-2018-business-eps1-up-1-4-at-cer/
  57. https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf
  58. https://en.sanofi.com/Images/49288_20-F_2016.pdf
  59. https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
  60. https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
  61. https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
  62. https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
  63. https://en.sanofi.com/Images/29804_20F_2011.pdf
  64. https://news.abbvie.com/news/abbvie-reports-second-quarter-2018-financial-results.htm
  65. "Financial Release - AbbVie". investors.abbvie.com.
  66. "Financial Release - AbbVie". investors.abbvie.com.
  67. "Financial Release - AbbVie". investors.abbvie.com.
  68. "Financial Release - AbbVie". investors.abbvie.com.
  69. "Financial Release - AbbVie". investors.abbvie.com.
  70. Mishra, Manas. http://www.abbottinvestor.com/static-files/9b97c378-cb63-402a-bbd9-cde779dc342e. Missing or empty |title= (help)
  71. Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  72. Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  73. "Abbott Reports Fourth-Quarter 2015 Results".
  74. "Abbott Reports Fourth-Quarter 2014 Results".
  75. Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  76. "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  77. "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma". www.fiercepharma.com.
  78. https://investor.lilly.com/static-files/8565700a-203e-4c17-8be3-748cc76e4762
  79. http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf
  80. "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  81. http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf
  82. http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf
  83. http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  84. http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  85. http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf
  86. http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-newsArticle&id=2360351
  87. "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  88. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
  89. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
  90. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
  91. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
  92. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
  93. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  94. https://www.businesswire.com/news/home/20180726005150/en/Bristol-Myers-Squibb-Reports-Quarter-Financial-Results
  95. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  96. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  97. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  98. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  99. "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  100. https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
  101. https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf
  102. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDA4OTU2fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636680582523475446
  103. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzk3OTQ3fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636534633626809804
  104. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzc2MjEyfENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636292722140277375
  105. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzI4OTExfENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=635944333723565434
  106. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mjc3NTQ3fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  107. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjI3MDc1fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  108. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTc2OTgyfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  109. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTMxNzQ1fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  110. https://www.astrazeneca.com/content/dam/az/PDF/2018/h1-2018/H1%202018%20Results%20announcement.pdf
  111. https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
  112. https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf
  113. "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  114. "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  115. "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  116. "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  117. "AstraZeneca PLC Fourth quarter and full year results 2011". www.astrazeneca.com.
  118. http://www.tevapharm.com/news/teva_reports_second_quarter_2018_financial_results_08_18.aspx
  119. "Teva Reports 2017 Full Year and Fourth Quarter Financial Results".
  120. http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx
  121. http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx
  122. "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  123. http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx
  124. http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2012_results_02_13.aspx
  125. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  126. "Boehringer Ingelheim 2017 Annual Report" (PDF). www.boehringer-ingelheim.com.
  127. 1 2 3 4 5 6 "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  128. https://www.merckgroup.com/content/dam/web/corporate/non-images/investors/reports-and-financials/earnings-materials/2018-q1/en/2018-Q1-Report-EN.pdf
  129. https://www.merckgroup.com/content/dam/web/corporate/non-images/investors/reports-and-financials/earnings-materials/2017-q4/en/2017-Q4-Report-EN.pdf
  130. http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf
  131. http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf
  132. http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf
  133. https://www.merckgroup.com/content/dam/web/corporate/non-images/investors/reports-and-financials/earnings-materials/2013-q4/en/2013-AR-EN.pdf
  134. https://www.merckgroup.com/content/dam/web/corporate/non-images/investors/reports-and-financials/earnings-materials/2012-q4/en/2012-AR-EN.pdf
  135. https://www.merckgroup.com/content/dam/web/corporate/non-images/investors/reports-and-financials/earnings-materials/2011-q4/en/2011-Merck-Annual-Report-EN.pdf
  136. https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2018/20180808_Financial%20statement_Q2%202018_UK.pdf
  137. "News details". www.novonordisk.com.
  138. https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf
  139. Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  140. Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  141. Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  142. Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  143. http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf
  144. http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyNzI0NDZ8Q2hpbGRJRD02OTc4MDc=
  145. 1 2 3 https://www.allergan.com/news/news/thomson-reuters/allergan-reports-solid-finish-to-2017
  146. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTczMDc2fENoaWxkSUQ9Mjc1MzEzfFR5cGU9MQ==&t=1
  147. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM5MDk2fENoaWxkSUQ9MjI4NjI0fFR5cGU9MQ==&t=1
  148. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTc3MTM2fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  149. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDYwMzczfENoaWxkSUQ9NDg4Mzk1fFR5cGU9MQ==&t=1
  150. https://www.takeda.com/newsroom/newsreleases/2018/takeda-reports-fy2017-full-year-results-and-issues-fy2018-guidance/
  151. http://investors.shire.com/~/media/Files/S/Shire-IR/quarterly-reports/2018/second-quarter-july2018-presentation.pdf
  152. "Shire reports 8% pro forma product sales and strong earnings growth resulting in record operating cash flow for full year 2017". www.shire.com.
  153. http://investors.shire.com/~/media/Files/S/Shire-IR/quarterly-reports/2017/full-year-2016-results.pdf
  154. http://investors.shire.com/~/media/Files/S/Shire-IR/annual-report-2015/shire-annual-report-2015.pdf
  155. http://investors.shire.com/~/media/Files/S/Shire-IR/events/year-2015/1fy-2014-earnings-presentation-final-12-feb-2015.pdf
  156. http://ar2013.shire.com/downloads/Shire_Annual_report_2013_financial_statements.pdf
  157. "Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013". investors.shire.com.
  158. http://investors.shire.com/~/media/Files/S/Shire-IR/annual-interim-reports/year-2011/annualreport2010170311.pdf
  159. http://ir.celgene.com/releasedetail.cfm?ReleaseID=1073027
  160. http://investors.biogen.com/static-files/44a04b54-7322-4009-8dfb-08cf7a79b80a
  161. "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 via www.bloomberg.com.
  162. http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf
  163. http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf
  164. http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf
  165. http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf
  166. http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf
  167. http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.